KRMDKORU Medical Systems, Inc.

Nasdaq korumedical.com


$ 2.50 $ -0.02 (-0.79 %)    

Friday, 13-Sep-2024 15:59:48 EDT
QQQ $ 474.86 $ 2.12 (0.45 %)
DIA $ 414.87 $ 2.97 (0.72 %)
SPY $ 561.82 $ 2.92 (0.52 %)
TLT $ 100.40 $ 0.27 (0.27 %)
GLD $ 238.66 $ 2.35 (0.99 %)
$ 2.5
$ 2.52
$ 2.49 x 100
-- x --
$ 2.48 - $ 2.54
$ 1.98 - $ 3.12
22,397
na
114.64M
$ 0.86
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2024 06-30-2024 10-Q
2 05-01-2024 03-31-2024 10-Q
3 03-13-2024 12-31-2023 10-K
4 11-08-2023 09-30-2023 10-Q
5 08-09-2023 06-30-2023 10-Q
6 05-04-2023 03-31-2023 10-Q
7 03-08-2023 12-31-2022 10-K
8 11-09-2022 09-30-2022 10-Q
9 08-03-2022 06-30-2022 10-Q
10 05-04-2022 03-31-2022 10-Q
11 03-02-2022 12-31-2021 10-K
12 11-10-2021 09-30-2021 10-Q
13 08-11-2021 06-30-2021 10-Q
14 05-12-2021 03-31-2021 10-Q
15 03-23-2021 12-31-2020 10-K
16 11-12-2020 09-30-2020 10-Q
17 08-05-2020 06-30-2020 10-Q
18 05-06-2020 03-31-2020 10-Q
19 03-04-2020 12-31-2019 10-K
20 11-06-2019 09-30-2019 10-Q
21 08-07-2019 06-30-2019 10-Q
22 05-07-2019 03-31-2019 10-Q
23 03-05-2019 12-31-2018 10-K
24 11-09-2018 09-30-2018 10-Q
25 08-06-2018 06-30-2018 10-Q
26 05-07-2018 03-31-2018 10-Q
27 11-03-2017 09-30-2017 10-Q
28 08-04-2017 06-30-2017 10-Q
29 05-05-2017 02-28-2017 10-K
30 01-05-2017 11-30-2016 10-Q
31 10-07-2016 08-31-2016 10-Q
32 06-30-2016 05-31-2016 10-Q
33 05-13-2016 02-29-2016 10-K
34 01-08-2016 11-30-2015 10-Q
35 10-02-2015 08-31-2015 10-Q
36 07-10-2015 05-31-2015 10-Q
37 05-08-2015 02-28-2015 10-K
38 01-14-2015 11-30-2014 10-Q
39 10-15-2014 08-31-2014 10-Q
40 07-15-2014 05-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 piper-sandler-maintains-overweight-on-koru-medical-systems-raises-price-target-to-3

Piper Sandler analyst Jason Bednar maintains KORU Medical Systems (NASDAQ:KRMD) with a Overweight and raises the price targe...

 koru-medical-systems-raises-2024-guidance-now-sees-revenue-of-32m-325m-prior-312m-332m-vs-31754m-estimate-expects-gross-margin-of-61-62

Raising full year 2024 revenue guidance to $32.0-$32.5 million, representing year-over-year growth of 12-14%; raising full ye...

 koru-medical-systems-q2-2024-adj-eps-001-beats-004-estimate-sales-8430m-beat-7570m-estimate

KORU Medical Systems (NASDAQ:KRMD) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of ...

 koru-medical-systems-promotes-christopher-pazdan-to-chief-operating-officer-effective-july-18-2024

KORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology compan...

 schott-pharma-and-koru-medical-systems-announce-collaboration-to-advance-large-volume-subcutaneous-infusion

The companies, KORU Medical, manufacturer of the proprietary, large-volume, Freedom Infusion System (the "Freedom System...

 koru-medical-systems-signs-supply-agreement-for-phase-iii-clinical-trial-for-a-novel-enzyme-replacement-therapy-to-treat-a-rare-endocrinological-disease

KORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology compan...

 koru-medical-systems-q1-2024-adj-eps-002-beats-004-estimate-sales-8198m-beat-7467m-estimate

KORU Medical Systems (NASDAQ:KRMD) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of ...

 koru-medical-systems-announces-successful-appeal-in-eu-notified-body-review

KORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology compan...

 b-riley-securities-reiterates-buy-on-koru-medical-systems-maintains-4-price-target

B. Riley Securities analyst William Woods reiterates KORU Medical Systems (NASDAQ:KRMD) with a Buy and maintains $4 price ta...

 koru-medical-systems-q4-2023-adj-eps-002-beats-004-estimate-sales-7186m-beat-6944m-estimate

KORU Medical Systems (NASDAQ:KRMD) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of ...

 earnings-scheduled-for-march-13-2024

Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share...

 koru-medical-systems-announced-a-clinical-supply-agreement-for-a-novel-subcutaneous-immunoglobulin-drug-entering-phase-3-trials

The custom product developed for this clinical trial under a prior agreement was built off the foundation of the KORU Medical F...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION